C12N 2795/10111
Myoviridae
C12N2795/10111 (Myoviridae) appears on 208 US grants and 346 published applications in this corpus.
Search patents in C12N- Granted patents
- 208
- Published applications
- 346
- Assignees
- 174
- Inventors
- 610
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 6 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 5 | 3 |
| 2003 | 1 | 8 |
| 2004 | 2 | 7 |
| 2005 | 1 | 6 |
| 2006 | 2 | 2 |
| 2007 | 3 | 3 |
| 2008 | 3 | 4 |
| 2009 | 3 | 4 |
| 2010 | 0 | 8 |
| 2011 | 5 | 10 |
| 2012 | 4 | 4 |
| 2013 | 2 | 6 |
| 2014 | 4 | 7 |
| 2015 | 3 | 12 |
| 2016 | 12 | 15 |
| 2017 | 12 | 24 |
| 2018 | 8 | 15 |
| 2019 | 18 | 23 |
| 2020 | 10 | 25 |
| 2021 | 16 | 37 |
| 2022 | 9 | 40 |
| 2023 | 20 | 21 |
| 2024 | 14 | 25 |
| 2025 | 20 | 21 |
| 2026 | 12 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2795/10132Use of virus as therapeutic agent, other than vaccineIndexing code88
- C12N 2795/10122New viral proteins or individual genes, new structural or functional aspects ofIndexing code75
- C12N 2795/10121Viruses as suchIndexing code70
- C12N 2795/10141Use of virus, viral particle or viral elements as a vectorIndexing code45
- C12N 2795/10131Uses of virus other than therapeutic or vaccineIndexing code32
- C12N 2795/10151Methods of production or purification of viral materialIndexing code28
- C12N 2795/10171Demonstrated in vivo effectIndexing code19
- C12N 2795/10123Virus like particles [vlp]Indexing code9
All 12 subgroupsShow fewer
Recent patents
- Bacteriophage effective for controlling Salmonella typhimurium and its derived biofilm, and an antibacterial composition comprising the same6 Oct 2026US 12,751,982 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Therapeutic bacteriophages22 Sep 2026US 12,742,158 B2University of Leicester
- Multimeric proteins for detecting a carbohydrate and/or treating a siglec-mediated disorder25 Aug 2026US 12,715,903 B2Palleon Pharmaceuticals Inc.
- Methods and systems for the rapid detection of Listeria using infectious agents28 Jul 2026US 12,692,482 B2Laboratory Corporation of America Holdings
- Methods for purifying bacteriophage and products of manufacture containing endotoxin-free bacteriophage preparations9 Jun 2026US 12,648,976 B2San Diego State University (SDSU) Foundation
- Peptide tags for phage imaging3 Sep 2026US 2026/0258373 A1The Regents of the University of California
- Bacteriophage(s) targeting capsular deficient klebsiella pneumoniae (kp), compositions comprising it(them) and use(s) thereof3 Sep 2026US 2026/0258374 A1
- Methods and compositions for conferring cellular resistance to viral infection3 Sep 2026US 2026/0258406 A1President and Fellows of Harvard College
- Systems and methods for generating bacteriophages adapted to infect a target bacterial strain20 Aug 2026US 2026/0242749 A1Baylor College of Medicine
- Listeria specific bacteriophage composition30 Jul 2026US 2026/0218134 A1Fundacion Azti-Azti Fundazioa
Most cited
By later US patents
- Autocatalytic replication of recombinant RNA181US 4,786,600 AThe Trustees of Columbia University in the City of New York · 1988
- Ribonuclease resistant viral RNA standards180US 5,677,124 AAmbion, Inc. · 1997
- Ribonuclease resistant RNA preparation and utilization80US 5,939,262 AAmbion, Inc. · 1999
- Altering microbial populations and modifying microbiota74US 9,701,964 B2SNIPR Technologies Limited · 2017
- Altering microbial populations and modifying microbiota53US 10,506,812 B2SNIPR Technologies Limited · 2019